BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29565268)

  • 1. Hinokitiol Inhibits Migration of A549 Lung Cancer Cells via Suppression of MMPs and Induction of Antioxidant Enzymes and Apoptosis.
    Jayakumar T; Liu CH; Wu GY; Lee TY; Manubolu M; Hsieh CY; Yang CH; Sheu JR
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hinokitiol Exerts Anticancer Activity through Downregulation of MMPs 9/2 and Enhancement of Catalase and SOD Enzymes: In Vivo Augmentation of Lung Histoarchitecture.
    Huang CH; Jayakumar T; Chang CC; Fong TH; Lu SH; Thomas PA; Choy CS; Sheu JR
    Molecules; 2015 Sep; 20(10):17720-34. PubMed ID: 26404213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Role of Hinokitiol Against H
    Xu Y; Wang S; Miao Q; Jin K; Lou L; Ye X; Xi Y; Ye J
    Curr Eye Res; 2017 Jan; 42(1):47-53. PubMed ID: 27269503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.
    Huang CH; Lu SH; Chang CC; Thomas PA; Jayakumar T; Sheu JR
    Eur J Pharmacol; 2015 Jan; 746():148-57. PubMed ID: 25449038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hinokitiol induces cell death and inhibits epidermal growth factor-induced cell migration and signaling pathways in human cervical adenocarcinoma.
    Wang CC; Chen BK; Chen PH; Chen LC
    Taiwan J Obstet Gynecol; 2020 Sep; 59(5):698-705. PubMed ID: 32917321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Cell Responses to Hinokitiol Treatment Result in Senescence or Apoptosis in Human Osteosarcoma Cell Lines.
    Yang SC; Chen HY; Chuang WL; Wang HC; Hsieh CP; Huang YF
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hinokitiol suppresses growth of B16 melanoma by activating ERK/MKP3/proteosome pathway to downregulate survivin expression.
    Wei KC; Chen RF; Chen YF; Lin CH
    Toxicol Appl Pharmacol; 2019 Mar; 366():35-45. PubMed ID: 30684529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE).
    Chen HY; Cheng WP; Chiang YF; Hong YH; Ali M; Huang TC; Wang KL; Shieh TM; Chang HY; Hsia SM
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells.
    Li LH; Wu P; Lee JY; Li PR; Hsieh WY; Ho CC; Ho CL; Chen WJ; Wang CC; Yen MY; Yang SM; Chen HW
    PLoS One; 2014; 9(8):e104203. PubMed ID: 25105411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase-3.
    Ido Y; Muto N; Inada A; Kohroki J; Mano M; Odani T; Itoh N; Yamamoto K; Tanaka K
    Cell Prolif; 1999 Feb; 32(1):63-73. PubMed ID: 10371304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases.
    Ma L; Wang R; Nan Y; Li W; Wang Q; Jin F
    Int J Oncol; 2016 Feb; 48(2):843-53. PubMed ID: 26692364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicological effects of NCKU-21, a phenanthrene derivative, on cell growth and migration of A549 and CL1-5 human lung adenocarcinoma cells.
    Liao HF; Pan CH; Chou PY; Chen YF; Wu TS; Sheu MJ; Wu CH
    PLoS One; 2017; 12(9):e0185021. PubMed ID: 28945763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
    Liu S; Yamauchi H
    Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapeutic strategy of hinokitiol in haemorrhagic shock-induced liver injury.
    Lu WJ; Lin KH; Tseng MF; Yuan KC; Huang HC; Sheu JR; Chen RJ
    J Cell Mol Med; 2019 Mar; 23(3):1723-1734. PubMed ID: 30548082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells.
    Chen X; Zhang X; Chen J; Yang Q; Yang L; Xu D; Zhang P; Wang X; Liu J
    Eur J Pharmacol; 2017 Nov; 815():147-155. PubMed ID: 28887042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells.
    Seo JS; Choi YH; Moon JW; Kim HS; Park SH
    BMC Cell Biol; 2017 Feb; 18(1):14. PubMed ID: 28241740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
    Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A flavonoid isolated from Streptomyces sp. (ERINLG-4) induces apoptosis in human lung cancer A549 cells through p53 and cytochrome c release caspase dependant pathway.
    Balachandran C; Sangeetha B; Duraipandiyan V; Raj MK; Ignacimuthu S; Al-Dhabi NA; Balakrishna K; Parthasarathy K; Arulmozhi NM; Arasu MV
    Chem Biol Interact; 2014 Dec; 224():24-35. PubMed ID: 25289772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hinokitiol reduces matrix metalloproteinase expression by inhibiting Wnt/β-Catenin signaling in vitro and in vivo.
    Li J; Zhou XD; Yang KH; Fan TD; Chen WP; Jiang LF; Bao JP; Wu LD; Xiong Y
    Int Immunopharmacol; 2014 Nov; 23(1):85-91. PubMed ID: 25169829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.